2024 Laboratory Reimbursement Trends and What to Expect in 2025
Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond
Lab Compliance Advisor
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Subscribe today for access to
Articles and Reports
Labs in Court: A Full Circle
Cases filed or resolved by the U.S. Department of Justice in the fourth quarter reveal the same compliance issues from early in 2024
Staffing: 2024’s Biggest Lab Operations Challenge
ADLM president Anthony Killeen looks at labs’ staffing struggles in 2024 and what can be done to alleviate them in the coming year
Labs Safe, but Marketing Company and Referring Physician Get In Trouble for Kickbacks
From - G2 Compliance Advisor
Once again, payments to physicians to induce referrals of lab tests has led to government enforcement efforts—but this time…
CMS Issues Deficiency Letter to Theranos
...
Already a member? Log in here
Know What’s Really Going On
...
Already a member? Log in here
Focus Medical Necessity Efforts on Three Core Elements
...
Already a member? Log in here
News at a Glance – Feb 2016
...
Already a member? Log in here
Long-Awaited Final Rule Clarifies 60-day Repayment Deadline
From - G2 Compliance Advisor
Labs and other providers are required by a provision enacted in the Affordable Care Act to return to Medicare overpayments within 60 days of…
HHS’ Top Ten Management Problems Include Labs
...
Already a member? Log in here
Pathway Genomics Denies Wrongdoing, Settles False Claims Allegations for $4 Million
From - G2 Compliance Advisor
As the year came to a close, the Federal Bureau of Investigation and the U.S. Attorney's Office announced December 30, 2015, a $4 million settlement with Pathway Genomics. The San Diego-based laboratory denied wrongdoing but agreed to pay that sum to resolve…